Beyond the incretin family , the broader metabolic research peptide category includes several compounds that engage body composition and metabolic biology through different receptor pathways than Retatrutide's triple-agonist mechanism
the FDA approved the first such drug, exenatide, in 2005
Safety profile : Whilst lower doses might theoretically reduce the incidence of dose-dependent adverse effects such as nausea and vomiting, this has not been systematically studied, and the overall risk-benefit ratio remains unknown
Antidepressants : While Semaglutide primarily acts on GLP-1 receptors, its indirect effects on appetite and mood may interact with the mechanisms of antidepressants
To view or add a comment, sign in More Relevant Posts Severe Infections Linked to Higher Risk of Mental and Neurological Disorders People hospitalised with severe infections may face a significantly higher risk of developing psychiatric and neurological conditions for up to two years after recovery, according to a large study published in JAMA Psychiatry